Garreth W. Lawrence

Effect of a bacteriocin-producing <i>Streptococcus salivarius</i> on the pathogen <i>Fusobacterium nucleatum</i> in a model of the human distal colon

Garreth W. Lawrence, Niamh McCarthy, Calum J. Walsh et al. · Gut Microbes · 2022 · 47 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12

Clinical and Genomic Characteristics of Patients with Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors

Xi Rao, Yongmei Chen, Julie Beyrer et al. · Clinical Cancer Research · 2023 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17

Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2− Metastatic Breast Cancer Treated with Abemaciclib

Emily Nash Smyth, Julie Beyrer, Kimberly R. Saverno et al. · Drugs - Real World Outcomes · 2022 · 13 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Nisin G is a novel nisin variant produced by a gut-derived <i>Streptococcus salivarius</i>

Garreth W. Lawrence, Enriqueta García-Gutiérrez, Calum J. Walsh et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 12 citations · Full text

Life Sciences, Microbiology, Molecular Biology +7

A gut-derived <i>Streptococcus salivarius</i> produces the novel nisin variant designated nisin G and inhibits <i>Fusobacterium nucleatum</i> in a model of the human distal colon microbiome

Garreth W. Lawrence, Enriqueta García-Gutiérrez, A. Kate O’Mahony et al. · mBio · 2024 · 11 citations · Full text

Life Sciences, Microbiology, Molecular Biology +11